When developing critical assays, such as liquid biopsy-based cancer tests and pre-natal genetic screening kits, the composition of blood collection tu…

With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…

Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …

Human blood is packed with genetic information found in circulating cell-free DNA (cfDNA) and cell-free RNA (RNA). Liquid biopsy takes advantage of th…

Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …

Streck Cyto-Chex® BCT effectively stabilizes immunomagnetic isolated Peripheral Blood Mononuclear Cells (PBMCs) for up to 7 days post blood collectio…

COVID-19 testing has brought non-blood based biological samples into the everyday life of researchers and people around the world. Before this new wav…

The goal of liquid biopsy moved closer to reality in past weeks. Liquid biopsy is the use of a bodily fluid to collect information from a distant site…

Streck recently presented data on our new and innovative blood collection tube, RNA Complete BCT®, at the American Association for Cancer Research (A…